+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glomerulonephritis Drug"

Glomerulonephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Glomerulonephritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Glomerulonephritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Glomerulonephritis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
Glomerulonephritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Glomerulonephritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 322 Pages
  • Global
From
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Glomerulonephritis is a type of kidney disorder that affects the glomeruli, the tiny filters in the kidneys that help remove waste from the blood. Treatment for glomerulonephritis typically involves medications to reduce inflammation, control blood pressure, and reduce proteinuria. Common drugs used to treat glomerulonephritis include ACE inhibitors, angiotensin receptor blockers, diuretics, and immunosuppressants. Liver and kidney disorders drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, and glomerulonephritis. These drugs can help reduce inflammation, control blood pressure, and reduce proteinuria. Common drugs used to treat liver and kidney disorders include antivirals, antifibrotics, and immunosuppressants. Some companies in the glomerulonephritis drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more